Prenatal Diagnostics Global Market Report 2023: Conventional Invasive Techniques Loose Sheen, Presenting Opportunities for Innovation
March 09, 2023 08:18 ET
|
Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "Prenatal Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Prenatal Diagnostics Market...
Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities
January 05, 2023 07:05 ET
|
Myriad Genetics, Inc.
Myriad Genetics continues to advance non-invasive prenatal screening with Prequel® and the forthcoming FirstGene™ test using AMPLIFY™ technology SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) --...
Insights on the Non Invasive Prenatal Testing $7.7 Billion Global Market to 2030 - Increasing Average Maternal Age and Rising Incidence of Chromosomal Syndromes Drives Growth
December 29, 2022 05:23 ET
|
Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report by Gestation Period, by Pregnancy Risk, by Method, by Technology, by...
$7.4 Billion Worldwide Non-Invasive Prenatal Testing Industry to 2027: Featuring Agilent Technologies, Berry Genetics, BGI Genomics and Eurofins Scientific Services Among Others
December 20, 2022 04:48 ET
|
Research and Markets
Dublin, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The "Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Reach Healthcare Announces Strategic Relationship With Zoom Video Communications, Inc. to Bring Seamless Access to Happy Mama's Maternity Care Services
November 29, 2022 13:01 ET
|
Reach Healthcare
SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Reach Healthcare is pleased to announce that Zoom Video Communications, Inc. is fully integrated into its Happy Mama App and Platform. This new...
Global Prenatal Genetic Testing Market Report 2022-2026: Technological Advancement and Low-Cost Solutions Present Opportunities
November 07, 2022 04:35 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Prenatal Genetic Testing - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. New technological advances in...
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
November 01, 2022 09:10 ET
|
Myriad Genetics, Inc.
$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal productsFast-growing SneakPeek test has helped 750,000 parents learn baby’s gender from home – earliest...
Start-Ups Take Center Stage at Happy Mama Expo's Maternity Tech Innovation Showcase
October 05, 2022 11:46 ET
|
Reach Healthcare
SAN DIEGO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- There is something for everyone at the Happy Mama Expo, Saturday, October 22nd from 7 AM to 7 PM Eastern. Topics range from prenatal and postpartum...
United Kingdom Non-Invasive Prenatal Testing Market Research Report 2022: Competitive Developments, Approaches, Recent Developments, M&A, Collaborations, Partnerships, Distribution, and Licensing
August 11, 2022 04:03 ET
|
Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "United Kingdom Non-Invasive Prenatal Testing Market and Forecasts 2022 - 2028" report has been added to ResearchAndMarkets.com's offering. The United...
Global Down Syndrome Foundation, the National Down Syndrome Congress, and the National Down Syndrome Society Highlight the FDA’s Public Warning About Risks Associated with Non-Invasive Prenatal Screening Tests
April 27, 2022 13:00 ET
|
Global Down Syndrome Foundation
Atlanta, Denver, New York, April 27, 2022 (GLOBE NEWSWIRE) -- Last week, the U.S. Food and Drug Administration (FDA) warned the public of the risk of false results, inappropriate use, and...